Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis

Background Combination therapy with immune checkpoint inhibitors (ICIs) and antiangiogenic agents is generally effective and well tolerated and might be effective for metastatic urothelial carcinoma (UC). However, ICI treatment is often associated with unique responses, such as pseudoprogression and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in oncology 2021-02, Vol.10, p.611810, Article 611810
Hauptverfasser:	Yang, Zizhong, Zhang, Guoqing, Sun, Qiong, Liu, Minglu, Shao, Jiakang, Jiao, Shunchang
Format:	Artikel
Sprache:	eng
Schlagworte:	anti-angiogenesis case report immune checkpoint inhibitor immune-related pneumonitis Life Sciences & Biomedicine Oncology pseudoprogression Science & Technology urothelial carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!